The effort required to achieve and maintain optimal glycemic control

被引:13
作者
Rosenthal, Elyse S. [2 ]
Bashan, Eran [3 ]
Herman, William H. [1 ]
Hodish, Israel [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Coll Elect Engn & Comp Sci EECS, Ann Arbor, MI 48105 USA
关键词
Insulin; Dosage adjustment; SUBCUTANEOUS INSULIN INFUSION; MULTIPLE DAILY INJECTIONS; TYPE-2; DIABETES-MELLITUS; 10-YEAR FOLLOW-UP; BASAL INSULIN; RANDOMIZED-TRIAL; OLDER-ADULTS; THERAPY; LISPRO; GLARGINE;
D O I
10.1016/j.jdiacomp.2011.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Insulin therapy is most effective when dosage is frequently adjusted. We sought to evaluate the effort required to maintain A1C below 7% once attained in older patients with type 2 diabetes. Methods: A total of 2380 insulin dosage adjustment episodes were analyzed for their intensity and frequency. The data were divided into an "induction period" (n=608), defined as the time before subjects' MC dropped below 7% for the first time, and a "maintenance period" (n=1772), defined as the remaining study period. The data originated from a published study and included 26 older subjects with suboptimally controlled type 2 diabetes treated for a year with intensive insulin therapy. To achieve therapy goals, the study team contacted the subjects once every few weeks, reviewed records and optimized the insulin dosage. Results: During both the induction and maintenance periods, insulin dosage (both long-acting and fast-acting) was adjusted by more than 20%. Maintaining A1C below 7% required dosage adjustments every 2.7(+/- 1.0) weeks, averaging 11.4% (+/- 4.0) in 2.0 (+/- 0.3) different components of insulin dosage (i.e., two of either long-acting or short-acting for breakfast, lunch or dinner) per contact. Conclusions: Considerable effort was required to maintain optimal MC levels in older patients with type 2 diabetes. Since the full benefit of insulin therapy is attained only when multiple components of insulin dosage are frequently adjusted and given the growing shortage of care providers' availability, innovative approaches are needed to empower patients to safely make their own insulin adjustments. Published by Elsevier Inc.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 23 条
[1]   Standards of Medical Care in Diabetes-2009 [J].
不详 .
DIABETES CARE, 2009, 32 :S13-S61
[2]   Adjust to target in type 2 diabetes - Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine [J].
Bergenstal, Richard M. ;
Johnson, Mary ;
Powers, Margaret A. ;
Wynne, Alan ;
Vlajnic, Aleksandra ;
Hollander, Priscilla ;
Rendell, Marc .
DIABETES CARE, 2008, 31 (07) :1305-1310
[3]   Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial [J].
Bretzel, Reinhard G. ;
Nuber, Ulrike ;
Landgraf, Wolfgang ;
Owens, David R. ;
Bradley, Clare ;
Linn, Thomas .
LANCET, 2008, 371 (9618) :1073-1084
[4]   DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes [J].
Buse, John B. ;
Woleeenbuttel, Bruce H. R. ;
Herman, William H. ;
Shemonsky, Natalie K. ;
Jiang, Honghua H. ;
Fahrbach, Jessie L. ;
Scism-Bacon, Jamie L. ;
Martin, Sherry A. .
DIABETES CARE, 2009, 32 (06) :1007-1013
[5]   A Randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control [J].
DeVries, JH ;
Snoek, FJ ;
Kostense, PJ ;
Masurel, N ;
Heine, RJ .
DIABETES CARE, 2002, 25 (11) :2074-2080
[6]   A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine [J].
Doyle, EA ;
Weinzimer, SA ;
Steffen, AT ;
Ahern, JAH ;
Vincent, M ;
Tamborlane, WV .
DIABETES CARE, 2004, 27 (07) :1554-1558
[7]  
Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
[8]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[9]  
Heinemann Lutz, 2002, Diabetes Technol Ther, V4, P673, DOI 10.1089/152091502320798312
[10]   A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes [J].
Herman, WH ;
Ilag, LL ;
Johnson, SL ;
Martin, CL ;
Sinding, J ;
Al Harthi, A ;
Plunkett, CD ;
LaPorte, FB ;
Burke, R ;
Brown, MB ;
Halter, JB ;
Raskin, P .
DIABETES CARE, 2005, 28 (07) :1568-1573